FDA Draft Guidance Extends Reprint Policy To Medical Reference Texts, Clinical Practice Guidelines
This article was originally published in The Gray Sheet
Executive Summary
FDA has revised, but not loosened, its 2009 policy on the practices manufacturers should follow when giving physicians reprints of journal articles and other publications that discuss unapproved uses of legally marketed medical devices and drugs.